The University of Pécs is working on vaccine development in partnership with the Austrian biotechnology company CEBINA. The Virological Research Group of the UP Szentágothai Research Centre started working with the Austrian company last year on active substance testing, and now they have achieved breakthrough success in vaccine development, so animal testing could begin soon. Prof. Ferenc Jakab, the leader of the Group explained that the vaccine developed by researchers in Pécs and Austria is different from Pfizer-BioNtech and Moderna vaccines now available in Hungary.

Read more:

• about the beginning of the joint development »
• about the Virological Research Group of UP »
• about the COVID-19 vaccination at UP »